Lower Omega-3 Status Associated with Higher Erythrocyte Distribution Width and Neutrophil-Lymphocyte Ratio in UK Biobank Cohort

Competing Interest Statement

Disclosures: M.I. McBurney has or has held consulting agreements in the past 3 years with the Council for Responsible Nutrition; Church & Dwight; DSM Nutritional Products; International Life Sciences Institute, North America; McCormick; PepsiCo; Smartech Topicals; and VitaMe Technologies. W.S. Harris holds an interest in OmegaQuant Analytics, a lab that offers omega-3 blood testing; and is a member of the RB Schiff Science and Innovation Advisory Board. N.L. Tintle has no conflicts to disclose.

Funding Statement

Sources of Support: This work was supported by the Fatty Acid Research Institute (FARI). FARI is a non-profit foundation bringing together nutrition scientists and biostatistical experts to accelerate discovery of the relationships between fatty acids, especially omega-3 fatty acids, and health. Analytic code will be made available upon request to the Fatty Acid Research Institute (https://www.faresinst.org/).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UK Biobank has ethical approval (Ref. 11/NW/0382) from the Northwest Multi-centre Research Ethics Committee as a Research Tissue Bank (RTB). All participants gave electronic signed informed consent. The UK Biobank study was conducted according to the guidelines laid down in the Declaration of Helsinki. The UK Biobank protocol is available online (http://www.ukbiobank.ac.uk/wp114content/uploads/2011/11/UK-Biobank-Protocol.pdf). The University of South Dakota Institutional Review Board reviewed and approved the use of de-identified data for research purposes (IRB-21-147).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes